1
|
Ocal R, Karakurum-Goksel B, Van M, Coskun O, Karaaslan C, Ucler S, Gokcay F, Celebisoy N, Sirin H, Kisabay Ak A, Saritas AS, Cerrahoglu Sirin T, Hasirci Bayir BR, Ekizoglu E, Orhan EK, Bayram D, Tanik N, Bicakci S, Ozturk V, Inan LE, Metin KM, Eren Y, Dora B, Oguz-Akarsu E, Karli N, Celik EU, Atalar AC, Gozubatik Celik RG, Mutluay B, Aydinlar EI, Yalinay Dikmen P, Semercioglu S, Emre U, Buldukoglu OC, Er B, Kilboz BB, Ibis S, Yagiz S, Koklu H, Kamaci I, Aliyeva G, Ates BE, Kara MM, Altunc FZ, Kaya I, Sisman C. Eating attitudes of migraine patients in Turkey: a prospective multi-center study. BMC Neurol 2024; 24:180. [PMID: 38811875 PMCID: PMC11134734 DOI: 10.1186/s12883-024-03672-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2024] [Accepted: 05/13/2024] [Indexed: 05/31/2024] Open
Abstract
BACKGROUND Migraine is a disease characterized by headache attacks. The disease is multifactorial in etiology and genetic and environmental factors play role in pathogenesis. Migraine can also be accompanied by psychiatric disorders like neurotism and obsessive compulsive disorder. Stress, hormonal changes and certain food intake can trigger attacks in migraine. Previous studies showed that eating attitudes and disorders are prevalant in patients with migraine. Eating disorders are psychiatric disorders related to abnormal eating habits. Both migraine and eating disorders are common in young women and personality profiles of these patient groups are also similar. A possible relationship which shows that migraine and eating habits are related can lead to a better understanding of disease pathogenesis and subsequently new therapeutic options on both entities. Association of migraine in relation to severity, depression and anxiety and eating habits and disorders were aimed to be investigated in this study. METHODS The study was designed as a prospective, multi-center, case control study. Twenty-one centers from Turkey was involved in the study. The gathered data was collected and evaluated at a single designated center. From a pool of 1200 migraine patients and 958 healthy control group, two groups as patient group and study group was created with PS matching method in relation to age, body-mass index, marital status and employment status. Eating Attitudes Test-26 (EAT-26), Beck's Depression Inventory (BDI) and Beck's Anxiety Inventory (BAI) were applied to both study groups. The data gathered was compared between two groups. RESULTS EAT-26 scores and the requirement for referral to a psychiatrist due to symptoms related to eating disorder were both statistically significantly higher in patient group compared to control group (p = 0.034 and p = 0.0001 respectively). Patients with migraine had higher scores in both BDI and BAI compared to control group (p = 0.0001 and p = 0.0001 respectively). Severity of pain or frequency of attacks were not found to be related to eating attitudes (r:0.09, p = 0.055). CONCLUSIONS Migraine patients were found to have higher EAT-26, BDI and BAI scores along with a higher rate of referral to a psychiatrist due to symptoms. Results of the study showed that eating habits are altered in migraine patients with higher risk of eating disorders. Depression and anxiety are also found to be common amongst migraine patients.
Collapse
Affiliation(s)
- Ruhsen Ocal
- Department of Neurology, University of Health Sciences, Antalya Training and Research Hospital, Antalya, Turkey.
| | - Basak Karakurum-Goksel
- Faculty of Medicine, Department of Neurology, Baskent University, Turgut Noyan Adana Hospital, Adana, Turkey
| | - Mert Van
- Department of Neurology, University of Health Sciences, Antalya Training and Research Hospital, Antalya, Turkey
| | - Ozlem Coskun
- Faculty of Medicine, Department of Neurology, Gazi University, Ankara, Turkey
| | - Cihad Karaaslan
- Faculty of Mediciene, Department of Neurology, Kirikkale University, Kirikkale, Turkey
| | - Serap Ucler
- Prof. Dr. Cemil Tascioglu City Hospital, Department of Neurology, Istanbul, Turkey
| | - Figen Gokcay
- Faculty of Medicine, Department of Neurology, Ege University, Izmir, Turkey
| | - Nese Celebisoy
- Faculty of Medicine, Department of Neurology, Ege University, Izmir, Turkey
| | - Hadiye Sirin
- Faculty of Medicine, Department of Neurology, Ege University, Izmir, Turkey
| | - Aysin Kisabay Ak
- Faculty of Medicine, Department of Neurology, Celal Bayar University, Manisa, Turkey
| | - Aysegul Seyma Saritas
- Faculty of Medicine, Department of Neurology, Celal Bayar University, Manisa, Turkey
| | - Tuba Cerrahoglu Sirin
- Department of Neurology, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey
| | - Buse Rahime Hasirci Bayir
- Department of Neurology, University of Health Sciences, Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey
| | - Esme Ekizoglu
- Faculty of Medicine, Department of Neurology, Istanbul University, Istanbul, Turkey
| | - Elif Kocasoy Orhan
- Faculty of Medicine, Department of Neurology, Istanbul University, Istanbul, Turkey
| | - Derya Bayram
- Department of Neurology, Adana City Training and Research Hospital, Adana, Turkey
| | - Nermin Tanik
- Faculty of Medicine, Department of Neurology, Yozgat Bozok University, Yozgat, Turkey
| | - Sebnem Bicakci
- Faculty of Medicine, Department of Neurology, Cukurova University, Adana, Turkey
| | - Vesile Ozturk
- Faculty of Medicine, Department of Neurology, Dokuz Eylul University, Izmir, Turkey
| | | | - Kubra Mehel Metin
- Department of Neurology, Ankara Training and Research Hospital, Ankara, Turkey
| | - Yasemin Eren
- Diskapi Training and Research Hospital, Department of Neurology, Ankara, Turkey
| | - Babur Dora
- Faculty of Medicine, Department of Neurology, Akdeniz University, Antalya, Turkey
| | - Emel Oguz-Akarsu
- Faculty of Medicine, Department of Neurology, Uludag University, Bursa, Turkey
| | - Necdet Karli
- Faculty of Medicine, Department of Neurology, Uludag University, Bursa, Turkey
| | - Emel Ur Celik
- Department of Neurology, Istanbul Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Turkey
| | - Arife Cimen Atalar
- Department of Neurology, Istanbul Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Turkey
| | - Rabia Gokcen Gozubatik Celik
- Istanbul Bakirkoy Prof Dr Osman Mental Health and Neurological Diseases Training and Research Hospital, Clinic of Neurology and Neurosurgery, Istanbul, Turkey
| | - Belgin Mutluay
- Istanbul Bakirkoy Prof Dr Osman Mental Health and Neurological Diseases Training and Research Hospital, Clinic of Neurology and Neurosurgery, Istanbul, Turkey
| | - Elif Ilgaz Aydinlar
- Faculty of Medicine, Department of Neurology, Acıbadem University, Istanbul, Turkey
| | - Pinar Yalinay Dikmen
- Faculty of Medicine, Department of Neurology, Acıbadem University, Istanbul, Turkey
| | - Sencer Semercioglu
- Department of Neurology, Ankara Training and Research Hospital, Ankara, Turkey
| | - Ufuk Emre
- Department of Neurology, Istanbul Training and Research Hospital, Istanbul, Turkey
| | - Osman Cagin Buldukoglu
- Department of Gastroenterology, University of Health Sciences, Antalya Training and Research Hospital, Antalya, Turkey
| | - Busra Er
- Prof. Dr. Cemil Tascioglu City Hospital, Department of Neurology, Istanbul, Turkey
| | - Bekir Burak Kilboz
- Prof. Dr. Cemil Tascioglu City Hospital, Department of Neurology, Istanbul, Turkey
| | - Seray Ibis
- Faculty of Medicine, Department of Neurology, Ege University, Izmir, Turkey
| | - Sibgetullah Yagiz
- Department of Neurology, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey
| | - Huzeyfe Koklu
- Department of Neurology, University of Health Sciences, Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey
| | - Ibrahim Kamaci
- Faculty of Medicine, Department of Neurology, Istanbul University, Istanbul, Turkey
| | - Gulshan Aliyeva
- Faculty of Medicine, Department of Neurology, Istanbul University, Istanbul, Turkey
| | - Basak Elcin Ates
- Faculty of Medicine, Department of Neurology, Cukurova University, Adana, Turkey
| | - Muge Mercan Kara
- Faculty of Medicine, Department of Neurology, Dokuz Eylul University, Izmir, Turkey
| | - Fatma Zehra Altunc
- Diskapi Training and Research Hospital, Department of Neurology, Ankara, Turkey
| | - Ilgin Kaya
- Faculty of Medicine, Department of Neurology, Akdeniz University, Antalya, Turkey
| | - Cagla Sisman
- Department of Neurology, Istanbul Training and Research Hospital, Istanbul, Turkey
| |
Collapse
|
2
|
Warren CM, Sehgal S, Nimmagadda SR, Gupta R. Prevalence and burden of coconut allergy in the United States. Ann Allergy Asthma Immunol 2023; 131:645-654.e2. [PMID: 37625503 PMCID: PMC10789306 DOI: 10.1016/j.anai.2023.08.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2023] [Revised: 08/05/2023] [Accepted: 08/11/2023] [Indexed: 08/27/2023]
Abstract
BACKGROUND Epidemiologic data on coconut allergy remains sparse in the United States despite the labeling requirement by the Food Allergen Labeling and Consumer Protection Act for products containing coconut. OBJECTIVE To provide current estimates of the prevalence, severity, determinants, and distribution of coconut allergy in the United States. METHODS A comprehensive food allergy prevalence survey was administered to a nationally representative, probability-based sample of US households between October 1, 2015 and September 30, 2016. Eligible respondents included adults who were able to complete self- and parent-proxy report surveys in English or Spanish by means of web or phone. RESULTS Using survey responses from 78,851 individuals, 0.39% (95% confidence interval [CI], 0.33-0.45) of the US general population were categorized as having convincing coconut allergy. Among children, 0.22% (95% CI, 0.16-0.30) were estimated to have coconut allergy compared with 0.43% (95% CI, 0.37-0.51) of adults, whereas only 0.12% (95% CI, 0.08-0.18) of these children and 0.20% (95% CI, 0.16-0.24) of adults with convincing immunoglobulin E (IgE)-mediated coconut allergy reported physician-confirmed diagnoses. A current epinephrine prescription was reported by 40.1% (95% CI, 33.3-47.4) of those with convincing coconut allergy. Reactions involving multiple organ systems were reported by 47.5% (95% CI, 40.1-54.9) of those with convincing coconut allergy. CONCLUSION Roughly 1 in 260 Americans report symptoms consistent with an IgE-mediated allergy to coconut, although fewer than half of these individuals report receiving a physician diagnosis. Our data indicate that most individuals with reported coconut allergy meeting symptom-based criteria for convincingly IgE-mediated disease have comorbid FAs, and for many patients, clinical management seems to be suboptimal.
Collapse
Affiliation(s)
- Christopher M Warren
- Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois; Center for Food Allergy and Asthma Research, Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
| | - Shruti Sehgal
- Center for Food Allergy and Asthma Research, Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois
| | - Sai R Nimmagadda
- Center for Food Allergy and Asthma Research, Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois; Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois; Division of Allergy and Immunology, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois
| | - Ruchi Gupta
- Center for Food Allergy and Asthma Research, Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois; Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois; Division of Allergy and Immunology, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois
| |
Collapse
|
3
|
Polaskey MT, Bendelow A, Mukherji J, Buranosky B, Silverberg JI, Fishbein A. Facial atopic dermatitis is associated with sensitization to cow's milk, egg whites, and peanuts in children under 36 months. Pediatr Dermatol 2023; 40:497-499. [PMID: 37037213 DOI: 10.1111/pde.15326] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/13/2022] [Accepted: 03/13/2023] [Indexed: 04/12/2023]
Abstract
Atopic dermatitis (AD) in early childhood often precedes the development of food sensitization and allergy, but the role of treating AD to prevent food allergy remains poorly understood. Our objective was to assess the relationship between facial dermatitis and food sensitization to cow's milk, egg whites, and peanuts in early childhood, as aggressive treatment of facial dermatitis could serve as a potential opportunity for food sensitization prevention. By 3 years of age, food sensitization levels to cow's milk, egg whites, and peanuts were 48% greater in children with facial AD than in children with no facial involvement of their AD. Additional research is needed to determine if facial involvement of AD in infants and young children is associated with increased food allergy.
Collapse
Affiliation(s)
| | - Anne Bendelow
- Ann and Robert H. Lurie Children's Hospital of Chicago, Data Analytics and Reporting, Chicago, Illinois, USA
| | - Janak Mukherji
- Division of Allergy & Immunology, Ann and Robert H Lurie Children's Hospital of Chicago, Chicago, Illinois, USA
| | - Brooke Buranosky
- Division of Allergy & Immunology, Ann and Robert H Lurie Children's Hospital of Chicago, Chicago, Illinois, USA
| | - Jonathan I Silverberg
- Department of Dermatology, The George Washington University School of Medicine and Health Sciences, Washington, DC, USA
| | - Anna Fishbein
- Division of Allergy & Immunology, Ann and Robert H Lurie Children's Hospital of Chicago, Chicago, Illinois, USA
- Division of Allergy & Immunology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
| |
Collapse
|
4
|
Kruse L, Lor J, Yousif R, Pongracic JA, Fishbein AB. Coconut allergy: Characteristics of reactions and diagnostic predictors in a pediatric tertiary care center. Ann Allergy Asthma Immunol 2021; 126:562-568.e1. [PMID: 33548470 DOI: 10.1016/j.anai.2021.01.027] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2020] [Revised: 01/04/2021] [Accepted: 01/19/2021] [Indexed: 01/17/2023]
Abstract
BACKGROUND Little is known on the clinical manifestations of coconut allergy. Our knowledge to date is mainly based on case reports. OBJECTIVE To characterize the allergic reactions to coconut and suggest diagnostic cutoffs for specific immunoglobulin E (sIgE) and skin prick testing (SPT) to predict clinically reactive coconut allergy. METHODS Methods include retrospective chart review at an urban tertiary care center of patients with positive testing result for coconut. Probability curves were computed by logistic regression for SPT and coconut sIgE. RESULTS Of 275 records reviewed, 69 patients reported coconut reactions and 206 were sensitized only or nonallergic. The reactions occurred with breastfeeding (n = 2), contact (n = 10), or oral ingestion (n = 57). Approximately 50% of oral ingestion reactions were associated with mild/moderate anaphylaxis. Clinical reactivity vs sensitization was more common in topical coconut users (2-fold) (P = .02). Although not statistically significant, there was a trend toward more coconut allergy vs sensitization in Asian and African American patients. The probability of allergy with positive SPT result was approximately 50% and with sIgE was approximately 60%. At an SPT of 9 mm wheal or sIgE of 58 kU of allergen/L, there is a 95% probability of reaction. Cosensitization with tree nuts, legumes, and seeds was common. Macadamia nut had the strongest correlation with coconut (r = 0.81, P < .001, n = 101). CONCLUSION Although the rate of reactivity to coconut in sensitized individuals is low, half of the reactions from consumption met the criteria for anaphylaxis. Clinicians should be aware of the spectrum of reactions and diagnostic use of sIgE and SPT.
Collapse
Affiliation(s)
- Lacey Kruse
- Department of Dermatology, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois
| | - Jennifer Lor
- Department of Pediatric Allergy & Immunology, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois
| | - Rame Yousif
- Department of Dermatology, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois
| | - Jacqueline A Pongracic
- Department of Pediatric Allergy & Immunology, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois
| | - Anna B Fishbein
- Department of Pediatric Allergy & Immunology, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
| |
Collapse
|
6
|
Abstract
Anaphylaxis is a severe and potentially life-threatening allergic reaction. There are numerous potential causes, with food allergy being the leading cause in children and the focus of this review. Most reactions involve an IgE-mediated mechanism, although non-IgE-mediated and nonimmunologic reactions can occur. Various cofactors to be discussed can place certain individuals at an increased risk of severe or fatal anaphylaxis. The clinical manifestations of anaphylaxis are broad and may involve multiple body systems. Diagnosis of food-related anaphylaxis is primarily based on signs and symptoms and supported, wherever possible, by identification and confirmation of a culprit food allergen. First-line treatment of anaphylaxis is intramuscular administration of epinephrine. Long-term management is generally focused on strict allergen avoidance and more recently on food desensitization using immunotherapy. This review provides an overview of anaphylaxis with a specific focus on food allergy.
Collapse
Affiliation(s)
- David Yue
- Division of Clinical Immunology & Allergy, Department of Medicine, Health Sciences Centre, McMaster University, Hamilton, ON, Canada
| | - Amanda Ciccolini
- Division of Clinical Immunology & Allergy, Department of Medicine, Health Sciences Centre, McMaster University, Hamilton, ON, Canada
| | - Ernie Avilla
- Division of Clinical Immunology & Allergy, Department of Medicine, Health Sciences Centre, McMaster University, Hamilton, ON, Canada
| | - Susan Waserman
- Division of Clinical Immunology & Allergy, Department of Medicine, Health Sciences Centre, McMaster University, Hamilton, ON, Canada
| |
Collapse
|